Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Itzhaki, 2018
FDA approval requires formal clinical trials, safety and efficacy review, labeling approval, and manufacturing validation under a New Drug Application (NDA) or Biologics License Application (BLA)
Research chemical vendors are not a recommended source regardless of price point or claimed purity
Well administer the NAD+ first via IV and then the glutathione immediately thereafter
AOD-9604 is named explicitly on the WADA 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times both in-competition and out-of-competition for all athletes under WADA jurisdiction
US$ 21.96
US$ 25.36
US$ 26.01
